|
1.
|
Details of PDMR/person closely associated with them (‘PCA’)
|
| a) |
Name |
Dr H Barron |
| b) |
Position/status |
Chief Scientific Officer and President, R&D |
| c) |
Initial notification/
amendment |
Initial notification |
|
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
| a) |
Name |
GSK plc |
| b) |
LEI |
5493000HZTVUYLO1D793 |
|
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
| a) |
Description of the financial instrument |
American Depositary Shares (‘ADSs’)
ISIN: US37733W1053 |
| b) |
Nature of the transaction |
Acquisition of notional ADSs within Dr Barron’s GSK Executive Supplemental Savings Plan account.
|
| c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
|
$44.7500 |
1,151.020 |
|
|
|
|
|
| d) |
Aggregated information |
N/A (single transaction) |
| Aggregated volume Price |
|
| e) |
Date of the transaction |
2022-05-23 |
| f) |
Place of the transaction |
New York Stock Exchange (XNYS) |